FIELD: medicine.
SUBSTANCE: invention refers to medicine, particularly to experimental nephrology and can be used for simulating generalised amyloidosis in animals for studying pathogenesis, prevention and treatment of amyloidosis. The method involves administering native sheep plasma into golden hamsters subcutaneously at 0.025 mg/g of body weight. Administering is performed for 30 experimental days.
EFFECT: method is easily reproducible, provides reducing the time of the simulation of the above pathology by greater antigenic strength of the selected protein preparation for the above animal series; the method enables studying the functional state of the renal system, mineral exchange and other body characteristics successfully.
1 ex, 2 tbl, 4 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR SIMULATION OF EXPERIMENTAL AMYLOIDOSIS IN ANIMALS | 2010 |
|
RU2446482C1 |
| METHOD FOR PREVENTION OF SYSTEMIC AMYLOIDOSIS AND ITS NEPHROPATHIC FORM IN EXPERIMENTAL ANIMALS | 2011 |
|
RU2473134C2 |
| METHOD FOR PREVENTION OF SYSTEMIC AMYLOIDOSIS AND ITS NEPHROPATHIC FORM IN EXPERIMENTAL ANIMALS | 2011 |
|
RU2473133C2 |
| METHOD FOR PREVENTION OF SYSTEMIC AMYLOIDOSIS AND ITS NEPHROPATHIC CONDITION IN EXPERIMENTAL ANIMALS | 2008 |
|
RU2386415C1 |
| METHOD OF EXPERIMENTAL AMYLOIDOSIS MODELLING IN ANIMALS | 2007 |
|
RU2347279C1 |
| METHOD OF SIMULATING AMYLOIDOSIS IN ANIMALS | 2008 |
|
RU2373581C1 |
| METHOD FOR PREVENTION OF SYSTEMIC AMYLOIDOSIS AND ITS NEPHROPATIC FORM IN EXPERIMENTAL ANIMALS | 2008 |
|
RU2381797C1 |
| METHOD OF PREVENTING SYSTEMIC AMYLOIDOSIS AND ITS NEPHROPATIC FORM IN EXPERIMENTAL ANIMALS | 2009 |
|
RU2410764C1 |
| METHOD OF MODELLING EXPERIMENTAL AMYLOIDOSIS IN RATS | 2009 |
|
RU2410761C1 |
| METHOD FOR MODELING EXPERIMENTAL AMYLOIDOSIS IN ANIMALS | 2006 |
|
RU2306617C1 |
